BioLife Solutions (BLFS) Misses Q3 EPS by 1c
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of $0.01, $0.01 worse than the analyst estimate of $0.02. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)